The pharmaceutical lactose market (Pharmazeutischer Laktosemarkt) growth can be attributed to the rising demand for orally disintegrating tablets (ODTs), as lactose acts as an excellent carrier for such formulations. Additionally, lactose’s biocompatibility and biodegradability enhance its appeal for use in various drug delivery systems. As the pharmaceutical industry focuses on patient-centric formulations, lactose aids in improving taste, texture, and stability of oral medications, ultimately enhancing patient compliance.
According to Future Market Insights’ latest analysis, the global pharmaceutical lactose Industry size is expected to reach US$ 222.6 million in 2023 and further expand at 5.8% CAGR throughout the forecast period (2023 to 2033). Overall sales of pharmaceutical lactose are projected to total a valuation of US$ 392.3 million in 2033.
Rising application of lactose as an ideal excipient across thriving pharmaceutical sector is a prominent factor driving the global market forward. Similarly, increasing prevalence of chronic diseases, development of new medicines, and increased investment in research & development are expected to facilitate expansion of the worldwide pharmaceutical lactose industry.
Over the years, lactose has become one of the most commonly used excipients in the pharmaceutical sector for producing a wide range of solid dosage forms. It finds application as a binder, carrier, or diluent and helps pharmaceutical companies to produce tablets of sufficient hardness.
Rising production and consumption of solid dosage forms such as capsules and tablets is expected to boost pharmaceutical lactose demand during the forecast period. Subsequently, growing demand for dry powder inhalation products will create growth opportunities for pharmaceutical lactose manufacturers.
Various forms of lactose i.e., α-lactose monohydrate, β-lactose, amorphous lactose, and spray dried lactose are being employed for manufacturing drugs.
Increasing healthcare awareness, especially across developing regions, growing popularity of preventive healthcare, and rising healthcare spending are expected to further expand the pharmaceutical lactose Industry size over the next ten years.
Pharmaceutical Lactose Market Insights
| Attribute | Key Insights |
|---|---|
| Pharmaceutical Lactose Market Estimated Value (2023) | US$ 222.6 million |
| Projected Market Value (2033) | US$ 392.3 million |
| Value-based CAGR (2023 to 2033) | 5.8% |
| Top 3 Countries’ Market Share | 18.2% |
Key Takeaways from the Pharmaceutical Lactose Market Study:
- Pharmaceutical lactose market is projected to surge at a CAGR of about 8% over the next ten years in Mexico.
- By product type, α-lactose monohydrate segment will continue to lead the global pharmaceutical lactose Industry during the forecast period.
- The United Kingdom pharmaceutical lactose market is anticipated to exceed a valuation of US$ 184.8 million by 2033.
- The USA is anticipated to hold around 78.3% share of North America pharmaceutical lactose market in 2023.
- Mexico is poised to hold around 5.3% of the global pharmaceutical lactose market by 2033.
Who is Winning?
DFE Pharma, Ba’emek Advanced Technologies Ltd (Tnuva Group), Avantor, Inc., Alpavit Käserei Champignon Hofmeister GmbH & Co. KG, Lactose (India) Limited, Hoogwegt Groep B.V., Hilmar Ingredients, Armor Pharma, Merck KgaA, Kerry plc, Milei GmbH, BASF SE, MEGGLE Excipients & Technology are few of the leading companies present in the global pharmaceutical lactose market.
Key pharmaceutical lactose companies are focusing on partnerships and joint ventures to expand their product portfolio and strengthen their supply chain.
Get Valuable Insights into Pharmaceutical Lactose Market
Future Market Insights, in its new offering, provides an unbiased analysis of the pharmaceutical lactose Industry presenting historical demand data (2018 to 2022) and forecast statistics for the period from (2023 to 2033). The study divulges compelling insights on the demand based on product type (β-Lactose, α-Lactose monohydrate, Amorphous lactose, Spray dried lactose) and region.
About the Food & Beverage Division at Future Market Insights
Expert analysis, actionable insights, and strategic recommendations- the food & beverage team at Future Market Insights helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.
Thorough Market Evaluation: Get Full Report
Pharmaceutical Lactose Market by Category
Product Type:
- β-lactose
- α-Lactose monohydrate
- Amorphous Lactose
- Spray Dried Lactose
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa
- Oceania
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
